Understanding how tobacco regulations may affect future rates of Chronic Obstructive Pulmonary Disease (COPD) in the US.
Modeling the impact of tobacco regulations on US future trends of Chronic Obstructive Pulmonary Disease.
This study is looking at how new rules about tobacco might help reduce the number of people getting Chronic Obstructive Pulmonary Disease (COPD) in the U.S., so we can better understand how cutting down on smoking can improve everyone's lung health.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-10911920 on NIH RePORTER |
What this research studies
This research focuses on creating a model to predict how future tobacco regulations will impact the rates of Chronic Obstructive Pulmonary Disease (COPD) in the United States. By analyzing individual smoking histories and the effects of regulatory actions by the FDA, the study aims to understand the long-term implications of reduced cigarette use on public health. The research will involve collaboration with experts in tobacco simulation modeling and regulatory science to ensure accurate predictions and effective policy recommendations. Patients may benefit from insights gained that could lead to improved tobacco control policies and ultimately better respiratory health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a history of smoking or those at risk for developing COPD due to tobacco use.
Not a fit: Patients who do not smoke and have no risk factors for COPD may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective tobacco regulations that significantly reduce the incidence of COPD and improve overall lung health in the population.
How similar studies have performed: Previous research has shown success in using simulation modeling to predict health outcomes related to tobacco use, indicating that this approach is both valid and valuable.
Where this research is happening
Washington, United States
- Georgetown University — Washington, United States (Active)
Researchers
- Principal investigator: Sanchez-Romero, Luz Maria — Georgetown University
- Study coordinator: Sanchez-Romero, Luz Maria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.